📖

North American Prodromal Synucleinopathy Consortium (NAPOS) Stage 2 — NCT05826457

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-north-american-prod

Related Entities

clinical-trials-north-american-prodromal-synucleinopathy-consortium-nct05826457

Metadata

slug	clinical-trials-north-american-prodromal-synucleinopathy-consortium-nct05826457
entity_type	clinical
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (16)

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

related🧫Cytochrome Therapeutics70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

related🧫Cytochrome Therapeutics70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%

mentions🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back40%

mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise40%

mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa40%

mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras40%

mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 40%